This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Regenecore Biotech Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jinguo Meng: Innovator in Biotech
Introduction
Jinguo Meng is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work focuses on advancing medical treatments through cutting-edge research and development.
Latest Patents
Jinguo Meng holds a patent for a "Humanized Anti-IL-4Ra Single Domain Antibody and Application Thereof." This invention represents a breakthrough in targeted therapies, offering potential benefits for patients suffering from various conditions related to IL-4Ra.
Career Highlights
Currently, Jinguo Meng is associated with Regenecore Biotech Co., Ltd. His role at the company allows him to leverage his expertise in biotechnology to drive forward innovative projects. His dedication to research and development has positioned him as a key figure in the industry.
Collaborations
Jinguo Meng collaborates with talented professionals in his field, including coworkers Yun Zhang and Yao Yao. These partnerships enhance the research capabilities at Regenecore Biotech Co., Ltd. and contribute to the advancement of their projects.
Conclusion
Jinguo Meng's contributions to biotechnology through his patent and work at Regenecore Biotech Co., Ltd. highlight his commitment to innovation in medical science. His efforts continue to pave the way for new therapeutic solutions that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile